Development and validation of a high-throughput screening assay for human long-chain fatty acid transport proteins 4 and 5

Journal of Biomolecular Screening

Volumn 15, Issue 5, 2010, Pages 488-497

  Zhou, Wei ^a   Madrid, Peter ^a   Fluitt, Amy ^b   Stahl, Andreas ^b   Xie, Xinmin ^a,c  

^a SRI INTERNATIONAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c AfaSci Inc   (United States)

Author keywords

Bile acids; Fatty acid transport proteins; Fluorometric imaging plate reader (FLIPR); High throughput screening; Long chain fatty acids

Indexed keywords

4 ARYL DIHYDROPYRIMIDINONE DERIVATIVE; BILE ACID; CHENODEOXYCHOLIC ACID; FATTY ACID TRANSPORTER; FATTY ACID TRANSPORTER 4; FATTY ACID TRANSPORTER 5; LONG CHAIN FATTY ACID; PYRIMIDINONE DERIVATIVE; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID;

ARTICLE; FATTY ACID TRANSPORT; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; IC 50; PRIORITY JOURNAL;

ANIMALS; CELL LINE; FATTY ACID TRANSPORT PROTEINS; FLUORESCENT DYES; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; MICE; MOLECULAR STRUCTURE; PYRIMIDINONES; REPRODUCIBILITY OF RESULTS;

MAMMALIA; RODENTIA;

EID: 77953632274     PISSN: 10870571     EISSN: 1552454X     Source Type: Journal    
DOI: 10.1177/1087057110369700     Document Type: Article

References (33)

1. Schaffer JE: A novel adipocyte long chain fatty acid transport protein. Eur J Med Res 1996 ; 1: 176-180.
2. Stahl A., Gimeno RE, Tartaglia LA, Lodish HF: Fatty acid transport proteins: a current view of a growing family. Trends Endocrinol Metab 2001 ; 12: 266-273.
3. Stremmel W., Pohl L., Ring A., Herrmann T.: A new concept of cellular uptake and intracellular trafficking of long-chain fatty acids. Lipids 2001 ; 36: 981-989.
4. Stahl A.: A current review of fatty acid transport proteins (SLC27). Pflugers Arch 2004 ; 447: 722-727.
5. Ehehalt R., Fullekrug J., Pohl J., Ring A., Herrmann T., Stremmel W.: Translocation of long chain fatty acids across the plasma membrane-lipid rafts and fatty acid transport proteins. Mol Cell Biochem 2006 ; 284: 135-140.
6. Hui TY, Bernlohr DA: Fatty acid transporters in animal cells. Front Biosci 1997 ; 2: d222 - d231.
7. Fitscher BA, Riedel HD, Young KC, Stremmel W.: Tissue distribution and cDNA cloning of a human fatty acid transport protein (hsFATP4). Biochim Biophys Acta 1998 ; 1443: 381-385.
8. Pohl J., Ring A., Ehehalt R., Herrmann T., Stremmel W.: New concepts of cellular fatty acid uptake: role of fatty acid transport proteins and of caveolae. Proc Nutr Soc 2004 ; 63: 259-262.
9. Pohl J., Ring A., Hermann T., Stremmel W.: Role of FATP in parenchymal cell fatty acid uptake. Biochim Biophys Acta 2004 ; 1686: 1-6. (Pubitemid 39446872)
10. Gimeno RE: Fatty acid transport proteins. Curr Opin Lipidol 2007 ; 18: 271-276.
11. Gimeno RE, Hirsch DJ, Punreddy S.,, et al. Targeted deletion of fatty acid transport protein-4 results in early embryonic lethality. J Biol Chem 2003 ; 278: 49512-49516.
12. Gimeno RE, Ortegon AM, Patel S.,, et al. Characterization of a heart-specific fatty acid transport protein. J Biol Chem 2003 ; 278: 16039-16044.
13. Koonen DP, Glatz JF, Bonen A., Luiken JJ: Long-chain fatty acid uptake and FAT/CD36 translocation in heart and skeletal muscle. Biochim Biophys Acta 2005 ; 1736: 163-180.
14. Richards MR, Harp JD, Ory DS, Schaffer JE: Fatty acid transport protein 1 and long-chain acyl coenzyme A synthetase 1 interact in adipocytes. J Lipid Res 2006 ; 47: 665-672.
15. Duttaroy AK: Transport of fatty acids across the human placenta: a review. Prog Lipid Res 2009 ; 48: 52-61.
16. Stahl A., Evans JG, Pattel S., Hirsch D., Lodish HF: Insulin causes fatty acid transport protein translocation and enhanced fatty acid uptake in adipocytes. Dev Cell 2002 ; 2: 477-488.
17. Kansara MS, Mehra AK, Von Hagen J., Kabotyansky E., Smith PJ: Physiological concentrations of insulin and T3 stimulate 3T3-L1 adipocyte acyl-CoA synthetase gene transcription. Am J Physiol 1996 ; 270 (pt 1). E873 - E881.
18. Steinberg GR, Bonen A., Dyck DJ: Fatty acid oxidation and triacylglycerol hydrolysis are enhanced after chronic leptin treatment in rats. Am J Physiol Endocrinol Metab 2002 ; 282: E593 - E600.
19. Basu A., Basu R., Shah P., Vella A., Rizza RA, Jensen MD: Systemic and regional free fatty acid metabolism in type 2 diabetes. Am J Physiol Endocrinol Metab 2001 ; 280: E1000 - E1006.
20. Fisher RM, Gertow K.: Fatty acid transport proteins and insulin resistance. Curr Opin Lipidol 2005 ; 16: 173-178.
21. Doege H., Baillie RA, Ortegon AM,, et al. Targeted deletion of FATP5 reveals multiple functions in liver metabolism: alterations in hepatic lipid homeostasis. Gastroenterology 2006 ; 130: 1245-1258.
22. Herrmann T., van der Hoeven F., Grone HJ,, et al. Mice with targeted disruption of the fatty acid transport protein 4 (FATP 4, Slc27a4) gene show features of lethal restrictive dermopathy. J Cell Biol 2003 ; 161: 1105-1115.
23. Hubbard B., Doege H., Punreddy S.,, et al. Mice deleted for fatty acid transport protein 5 have defective bile acid conjugation and are protected from obesity. Gastroenterology 2006 ; 130: 1259-1269.
24. Liao J., Sportsman R., Harris J., Stahl A.: Real-time quantification of fatty acid uptake using a novel fluorescence assay. J Lipid Res 2005 ; 46: 597-602.
25. Ho M., Foxall S., Higginbottom M.,, et al. Leptin-mediated inhibition of the insulin-stimulated increase in fatty acid uptake in differentiated 3T3-L1 adipocytes. Metabolism 2006 ; 55: 8-12.
26. Stahl A., Hirsch DJ, Gimeno RE,, et al. Identification of the major intestinal fatty acid transport protein. Mol Cell 1999 ; 4: 299-308.
27. Li H., Black PN, DiRusso CC: A live-cell high-throughput screening assay for identification of fatty acid uptake inhibitors. Anal Biochem 2005 ; 336: 11-19.
28. Li H., Black PN, Chokshi A.,, et al. High-throughput screening for fatty acid uptake inhibitors in humanized yeast identifies atypical antipsychotic drugs that cause dyslipidemias. J Lipid Res 2008 ; 49: 230-244.
29. Blackburn C., Guan B., Brown J.,, et al. Identification and characterization of 4-aryl-3,4-dihydropyrimidin-2(1H)-ones as inhibitors of the fatty acid transporter FATP4. Bioorg Med Chem Lett 2006 ; 16: 3504-3509.
30. Zhang JH, Chung TD, Oldenburg KR: A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 1999 ; 4: 67-73.
31. Staels B., Fonseca VA: Bile acids and metabolic regulation: mechanisms and clinical responses to bile acid sequestration. Diabetes Care 2009 ; 32 (suppl 2). S237 - S245.
32. Xie XM, Van Deusen AL, Vitko I., Barrett PQ, Huynh N., Cheng H.,, et al. Validation of high throughput screening assays against three subtypes of Cav3 T-type channels using molecular and pharmacologic approaches. Assay Drug Dev Technol 2007 ; 5: 191-203.
33. Sandoval A., Fraisl P., Arias-Barrau E.,, et al. Fatty acid transport and activation and the expression patterns of genes involved in fatty acid trafficking. Arch Biochem Biophys 2008 ; 477: 363-371.